Skip to main
CINC

CinCor Pharma (CINC) Earnings Dates & Reports

CinCor Pharma (CINC) Most Recent Earnings

Report Date
Period EndingQ3 2022
Est. EPS-$0.61
Actual EPS-$0.51
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CinCor Pharma (CINC) Earnings per Share (EPS) History

Signup for full access
Browse free

CinCor Pharma (CINC) Latest Earnings

The value each CINC share was expected to gain vs. the value each share gained.

CinCor Pharma (CINC) reported its most recent earnings on for Q3 2022, posting earnings per share (EPS) of -$0.51. This exceeded analysts' expectations of -$0.61 by 16.39%, marking a Beat.

For comparison, CinCor Pharma reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

CinCor Pharma (CINC) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2022
-$0.61-$0.51-16.39%
DeckReportListen
Q2 2022
-$0.50-$0.56+12.00%
DeckReportListen
Q1 2022
-$0.50-$0.500.00%
DeckReportListen
Q4 2021
-$1.56-$15.71+907.05%
DeckReportListen

CinCor Pharma (CINC) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the CinCor Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

CinCor Pharma (CINC) Earnings FAQs

CinCor Pharma (CINC) last reported earnings on Nov 3, 2022 for Q3 2022, posting an EPS of -$0.51, which Beat the estimate of -$0.61 by 16.39%.

For Q3 2022, CinCor Pharma (CINC) reported an EPS of -$0.51, exceeding analysts' estimate of -$0.61 by 16.39%.

For Q3 2022, CinCor Pharma (CINC) Beat expectations with an actual EPS of -$0.51 vs. an estimated EPS of -$0.61.

Following the last earnings report on Nov 3, 2022, CinCor Pharma (CINC)'s stock price moved — from — to —.

The next CinCor Pharma (CINC) earnings call is scheduled for Nov. 3, 2022, where executives will discuss financial results and outlook.

CinCor Pharma (CINC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.